| P50 | author | Jaime Modiano | Q42696815 |
| | Jakub Tolar | Q34445573 |
| P2093 | author name string | Jerome Schaack | |
| | Ron T McElmurry | |
| | Timothy D O'Brien | |
| | Colleen L Forster | |
| | Donald Bellgrau | |
| | Beth A Lindborg | |
| | Edward A Zamora | |
| | Mitzi Lewellen | |
| P2860 | cites work | Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha | Q39635625 |
| | Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells | Q40216419 |
| | Sarcoma derived from cultured mesenchymal stem cells | Q40220522 |
| | Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells | Q40648250 |
| | Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells | Q40961056 |
| | Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury | Q42210750 |
| | Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages | Q42253863 |
| | Differential anti-inflammatory and anti-fibrotic activity of transplanted mesenchymal vs. hematopoietic stem cells in carbon tetrachloride-induced liver injury in mice | Q43166981 |
| | Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma | Q43854472 |
| | Mesenchymal stem cells alleviate experimental asthma by inducing polarization of alveolar macrophages | Q45848683 |
| | Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. | Q45896896 |
| | Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells | Q47318047 |
| | Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes. | Q54097743 |
| | Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction | Q56901258 |
| | Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB | Q60394821 |
| | Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation | Q61976669 |
| | Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals | Q62083511 |
| | Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape | Q71762882 |
| | A trial to kill tumor cells through Fas (CD95)-mediated apoptosis in vivo | Q71783548 |
| | Antitumor effect of locally produced CD95 ligand | Q73034275 |
| | Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance | Q73476243 |
| | Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors | Q77198580 |
| | Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells | Q77841668 |
| | Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients | Q81676895 |
| | Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect | Q82137386 |
| | Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report | Q84931084 |
| | IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells | Q87057765 |
| | Fusion of HepG2 cells with mesenchymal stem cells increases cancer‑associated and malignant properties: an in vivo metastasis model | Q88074024 |
| | Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation | Q27026193 |
| | T cell exclusion, immune privilege, and the tumor microenvironment | Q28259872 |
| | Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile | Q33532608 |
| | Gene transfer of Fas ligand induces tumor regression in vivo | Q33731661 |
| | Homologous mesenchymal stem cells promote the emergence and growth of pulmonary metastases of the rat osteosarcoma cell line UMR-106 | Q33778236 |
| | Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging | Q34164696 |
| | Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages | Q34502380 |
| | Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer | Q34592559 |
| | Fas-ligand--iron fist or Achilles' heel? | Q34623195 |
| | A cytokine-mediated link between innate immunity, inflammation, and cancer | Q34625152 |
| | Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment. | Q34633575 |
| | Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis | Q35946990 |
| | Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring | Q36048767 |
| | The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression | Q36179636 |
| | The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand | Q36367323 |
| | CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα | Q36456715 |
| | Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer | Q36460454 |
| | Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report. | Q36501180 |
| | Adenoviral-mediated gene transfer in lymphocytes. | Q36641367 |
| | MHC-dependent desensitization of intrinsic anti-self reactivity | Q36978119 |
| | Type I interferon as a stimulus for cross-priming | Q37027815 |
| | Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. | Q37241672 |
| | Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells | Q37294845 |
| | Bone marrow-derived mesenchymal stem cells and the tumor microenvironment | Q37735741 |
| | Chemoimmunotherapy: reengineering tumor immunity | Q38079749 |
| | Social networking of human neutrophils within the immune system | Q38219743 |
| | Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment | Q38363548 |
| P433 | issue | 11 | |
| P304 | page(s) | 1449-1460 | |
| P577 | publication date | 2015-08-07 | |
| P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
| P1476 | title | Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment | |
| P478 | volume | 64 | |